Brand Insights - Thought Leadership | Paid Program | Fingerpaint Group

An evolving system requires a focus on digital channels

Why it’s important to integrate patient assistance programs for cell and gene therapies into the overall clinical development plan.

2020 is the year of reimagination.

New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.

The foundation of a strong rare disease marketing program must be built on the comprehensive knowledge of how the life-altering disease impacts all areas of a patient’s life.

The rise of digital has enhanced our ability to personalize our marketing messages and engage our target audiences more effectively